Evidence map›Paper›PMID 35712303›Full record

Observational studyFrontiers in public health2022

HCV Self-Testing to Expand Testing: A Pilot Among Men Who Have Sex With Men in China.

Wenqian Xu, Elena Ivanova Reipold, Peizhen Zhao, Weiming Tang, Joseph D Tucker, Jason J Ong, Jinshen Wang, Philippa Easterbrook, Cheryl Case Johnson, Muhammad S Jamil and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Wenqian XuSchool of Public Health, Southern Medical University, Guangzhou, China.
Elena Ivanova ReipoldThe Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Peizhen ZhaoDermatology Hospital of Southern Medical University, Guangzhou, China.
Weiming TangDermatology Hospital of Southern Medical University, Guangzhou, China.
Joseph D TuckerFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Jason J OngFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Jinshen WangSchool of Public Health, Southern Medical University, Guangzhou, China.
Philippa EasterbrookDepartment of Global HIV, Hepatitis, and STI Programmes, World Health Organization, Geneva, Switzerland.
Cheryl Case JohnsonDepartment of Global HIV, Hepatitis, and STI Programmes, World Health Organization, Geneva, Switzerland.
Muhammad S JamilDepartment of Global HIV, Hepatitis, and STI Programmes, World Health Organization, Geneva, Switzerland.
Cheng WangSchool of Public Health, Southern Medical University, Guangzhou, China.
Guangdong Provincial Center for Disease Control and Prevention · CNWorld Health Organization · CHLondon School of Hygiene & Tropical Medicine · GBFoundation for Innovative New Diagnostics · CHGuangzhou University · CNSouthern Medical University · CN

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Hepatitis C virus self-testing (HCVST) may increase test uptake especially among marginalized key populations such as men who have sex with men (MSM). We conducted an observational study to assess the usability, acceptability and feasibility of HCVST among MSM in China. Methods: An observational study with convenience sampling was performed among MSM in Guangzhou, China in 2019. The OraQuick® HCV Rapid Antibody Test kits were used in this study. Participants performed all 12 HCVST steps and interpreted the results in the presence of a trained observer. Usability was defined as the number and percentage of participants who completed all testing steps correctly without assistance and interpreted the results correctly. Inter-reader concordance was calculated as the percentage agreement between the results interpreted by the participant and those interpreted by a trained staff member. The same process was used to estimate inter-operator agreement between the self-testing and professional use test results. Acceptability was assessed using an interviewer-administered semi-structured questionnaire. Results: Among 100 participants with median age 27 (interquartile range 23-30) years, 4% reported prior history of HCV testing, 41% reported using blood-based HIV self-testing in the past, 54% (95%CI: 43.7-64.0%) completed all self-testing steps correctly without assistance and interpreted the results correctly. Both the inter-reader and inter-operator concordance were excellent at 97% (95%CI: 91.5-99.4%) and 98% (95%CI: 93.0-99.8%), respectively. The majority rated the HCVST process as very easy (52%, 95%CI: 41.8-62.1%) or easy (41%, 95%CI: 31.3-51.3%), 76% (95%CI: 66.4-84.0%) were willing to use HCVST again, and 75% (95%CI: 65.3-83.1%) would recommend it to their family and friends. Conclusions: Our findings demonstrate that oral fluid HCVST has high usability and acceptability among Chinese MSM. More implementation research is needed to plan how best to position and scale-up HCVST alongside other facility-and community-based testing approaches and ensure data linkage into health systems.

Indexed as

Hepatitis CHIV InfectionsSexual and Gender MinoritiesAdultChinaHepacivirusHomosexuality, MaleHumansMaleSelf-TestingYoung AdultChinahepatitis C virusmen who have sex with menrapid diagnostic testsself-testing

Identifiers

PMID35712303
PMCPMC9194083
OpenAlexW4281708650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.